MS
OSIR

Murray Stahl’s Osiris Therapeutics, Inc. Common Stock OSIR Stock Holding History

Murray Stahl’s Portfolio OSIR Stock Details OSIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-19,000
Closed -$361K – 502
2019
Q1 		$361K Buy
+19,000
New +$308K 0.01% 308

Other funds holding OSIR

FGAM
Financial Gravity Asset Management Lakeway, Texas $562M AUM

Murray Stahl's OSIR Position: Q2 2019 in Review

Murray Stahl sold out of Osiris Therapeutics, Inc. Common Stock (OSIR) in Q2 2019, closing a stake of 19,000 shares — an estimated $361K sold.

Murray Stahl first reported a position in OSIR in Q1 2019 and held it in 1 quarter. The position peaked at $361K in Q1 2019. 1 fund tracked by Wall St. Rank holds OSIR as of Q2 2019.

  • Murray Stahl reported no remaining Osiris Therapeutics, Inc. Common Stock position as of Q2 2019 after selling out during the quarter.
  • Murray Stahl sold 19,000 Osiris Therapeutics, Inc. Common Stock shares in Q2 2019, an estimated $361K.
  • Murray Stahl first reported a position in Osiris Therapeutics, Inc. Common Stock in Q1 2019 and held it in 1 quarter.
  • Murray Stahl's Osiris Therapeutics, Inc. Common Stock position peaked at $361K in Q1 2019.
  • 1 fund tracked by Wall St. Rank held Osiris Therapeutics, Inc. Common Stock as of Q2 2019.

Based on Horizon Kinetics Asset Management's 13F filing for Q2 2019, filed 14 Aug 2019.